Search Results - "Dodick, David W."

AUTHOR RESPONSE.

Authors: Dodick, David W. Turkel, Catherine C. Degryse, Ronald E. et al.

Source: Headache Jun2011; Vol. 51 (6).

Journal Info: Publisher: Wiley-Blackwell ISSN: 0017-8748

Factors associated with subjective cognitive complaints in former American football players.

Authors: Adler, Jennifer S. Ly, Monica T. Yhang, Eukyung et al.

Source: Journal of the International Neuropsychological Society; Feb2026, Vol. 32 Issue 2, p132-146, 15p

Integrating gepants into clinical practice for the acute treatment of migraine.

Authors: Lipton, Richard B. Dodick, David W. Davis, Linda et al.

Source: Headache: The Journal of Head & Face Pain. Apr2026, Vol. 66 Issue 4, p976-989.

Comprehensive assessment of erenumab efficacy in participants with high‐frequency episodic migraine with at least one previously failed preventive treatment: The EMBRACE study.

Authors: Paiva da Silva Lima, Gabriel Rao, Renata Szabó, Gyöngyi et al.

Source: Headache: The Journal of Head & Face Pain. Mar2026, Vol. 66 Issue 3, p658-671.

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper.

Authors: Newman, Lawrence C. Lay, Christine Lipton, Richard B. et al.

Source: Headache: The Journal of Head & Face Pain. Feb2026, Vol. 66 Issue 2, p428-439.

Vancouver Declaration II on Global Headache Patient Advocacy 2019.

Authors: Dodick, David W Ashina, Messoud Sakai, Fumihiko et al.

Source: Cephalalgia. Sep2020, Vol. 40 Issue 10, p1017-1025. 9p.

Efficacy of MEDI0618, a pH-dependent monoclonal antibody targeting PAR2, in preclinical models of migraine.

Authors: Kopruszinski, Caroline M Linley, John E Thornton, Peter et al.

Source: Brain: A Journal of Neurology; Apr2025, Vol. 148 Issue 4, p1345-1359, 15p

Shift in diagnostic classification of migraine after initiation of preventive treatment with eptinezumab: post hoc analysis of the PROMISE studies.

Authors: Pozo-Rosich, Patricia Dodick, David W. Ettrup, Anders et al.

Source: BMC Neurology. 10/25/2022, Vol. 22 Issue 1, p1-10. 10p.

Neuropsychological test performance of former American football players.

Authors: Alosco, Michael L. Barr, William B. Banks, Sarah J. et al.

Source: Alzheimer's Research & Therapy. 1/6/2023, p1-13. 13p.

Characterizing the patient experience during the prodrome phase of migraine: A qualitative study of symptoms and their timing.

Authors: Lipton, Richard B. Stokes, Jonathan Evans, Christopher J. et al.

Source: Headache: The Journal of Head & Face Pain. Sep2025, Vol. 65 Issue 8, p1355-1368.

International Headache society evidence-based guidelines on the use of non-invasive neuromodulation devices for the acute and preventive treatment of migraine.

Authors: Yuan, Hsiangkuo Orr, Serena L. Al-Karagholi, Mohammad A.M. et al.

Source: Cephalalgia. Oct2025, Vol. 45 Issue 10, p1-29. 29p.

Baseline Normative and Test–Retest Reliability Data for Sideline Concussion Assessment Measures in Youth.

Authors: Wethe, Jennifer V. Bogle, Jamie Dodick, David W. et al.

Source: Diagnostics (2075-4418). Aug2024, Vol. 14 Issue 15, p1661. 14p.

Benefits Beyond Headache Days With OnabotulinumtoxinA Treatment: A Pooled PREEMPT Analysis.

Authors: Diener, Hans-Christoph Dodick, David W. Lipton, Richard B. et al.

Source: Pain & Therapy. Dec2020, Vol. 9 Issue 2, p683-694. 12p.

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment.

Authors: Dodick, David W Goadsby, Peter J Lucas, Christian et al.

Source: Cephalalgia. Aug2020, Vol. 40 Issue 9, p935-948. 14p. 1 Diagram, 4 Charts, 2 Graphs.

Effect of erenumab versus other migraine preventive medications on cardiovascular and cerebrovascular outcomes: A United States claims database‐based observational cohort study.

Authors: Dodick, David W. Tepper, Stewart J. Ailani, Jessica et al.

Source: Headache: The Journal of Head & Face Pain. Jun2025, Vol. 65 Issue 6, p919-932.

Weight loss with atogepant during the preventive treatment of migraine: A pooled analysis.

Authors: Peterlin, B. Lee Bond, Dale S. Ailani, Jessica et al.

Source: Cephalalgia. Dec2024, Vol. 44 Issue 12, p1-11. 11p.

An objective neurophysiological study of subconcussion in female and male high school student athletes.

Authors: D'Arcy, Ryan C. N. McCarthy, David Harrison, Derek et al.

Source: Scientific Reports. 11/22/2024, Vol. 14 Issue 1, p1-12. 12p.

Hypersensitivity to PACAP-38 in post-traumatic headache: a randomized clinical trial.

Authors: Al-Khazali, Haidar M Christensen, Rune H Dodick, David W et al.

Source: Brain: A Journal of Neurology; Apr2024, Vol. 147 Issue 4, p1312-1320, 9p

Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial.

Authors: Dodick, David W Lipton, Richard B Silberstein, Stephen et al.

Source: Cephalalgia. Aug2019, Vol. 39 Issue 9, p1075-1085. 11p. 1 Diagram, 2 Charts, 2 Graphs.

Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex.

Authors: Porreca, Frank Navratilova, Edita Dodick, David W

Source: Cephalalgia. May2025, Vol. 45 Issue 5, p1-5. 5p.